← Open Payments lookup

ASHLEY O'FLYNN: Open Payments

NPI 1093420044 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$917 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $346 · 2025 $917

Food & beverage: $917
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.10$218
ABBVIE INC.7$182
Janssen Biotech, Inc.3$177
Mallinckrodt Hospital Products Inc.1$146
Madrigal Pharmaceuticals1$128
Aimmune Therapeutics, Inc.2$33
Phathom Pharmaceuticals, Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: DUPIXENT, TREMFYA, TERLIVAZ, REZDIFFRA, SKYRIZI, RINVOQ, ZENPEP, LINZESS.

Industry payments across LA — which companies pay providers there.